Qube Research & Technologies (QRT)’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-130,289
| Closed | -$1.37M | – | 3126 |
|
|
2024
Q4 | $1.37M | Buy |
130,289
+90,593
| +228% | +$956K | ﹤0.01% | 1621 |
|
|
2024
Q3 | $576K | Buy |
+39,696
| New | +$576K | ﹤0.01% | 1838 |
|
|
2024
Q2 | – | Sell |
-12,633
| Closed | -$129K | – | 4131 |
|
|
2024
Q1 | $129K | Buy |
+12,633
| New | +$129K | ﹤0.01% | 2737 |
|
|
2023
Q2 | – | Sell |
-77,369
| Closed | -$504K | – | 2883 |
|
|
2023
Q1 | $504K | Buy |
77,369
+48,532
| +168% | +$316K | ﹤0.01% | 1501 |
|
|
2022
Q4 | $246K | Buy |
28,837
+12,412
| +76% | +$106K | ﹤0.01% | 1657 |
|
|
2022
Q3 | $87K | Sell |
16,425
-1,441
| -8% | -$7.63K | ﹤0.01% | 1964 |
|
|
2022
Q2 | $76K | Buy |
+17,866
| New | +$76K | ﹤0.01% | 2015 |
|
|
2021
Q1 | – | Sell |
-19,484
| Closed | -$903K | – | 2382 |
|
|
2020
Q4 | $903K | Buy |
+19,484
| New | +$903K | 0.01% | 907 |
|